skull. The lesion exhibited aggressive behavior toward the outer table but not the adjacent structures such as the galea or dura mater. On MRI an intradiploic mass measured 2 × 2.3 × 6.8 cm; it was well demarcated from surrounding bone and displayed an isointense stroma on T1-and T2-weighted sequences in relation to the cerebrospinal fluid, with no restricted diffusion on diffusion-weighted imaging and periphery enhancement with gadolinium ( Fig. 2) .
Observing the clinical and radiographic characteristics, we considered intraosseous cavernous hemangioma to be the most likely diagnosis since the lesion was well demarcated from the galea without surrounding edema and had the expected radiographic findings. Nevertheless extracranial meningioma was another suspected diagnosis in that the lesion had a homogeneous appearance and enhanced after intravenous injection of contrast. The possibility of JPOF was not considered before surgery.
Operation
Excision was performed via open craniotomy. Because of the localization of the lesion, its dimensions, and our suspected diagnosis, we opted for total removal in 1 piece with at least 1 cm of security margins. The lesion was excised "en bloc"; the piece was heterogeneous with a translucent blue part suggestive of an aneurysmal cyst. The underlying dura mater was intact. The defect was covered with a bone replacement system. We used a biocompatible material made of tetracalcium phosphate, tricalcium phosphate, and hydroxyapatite.
Postoperative Course
The patient's postoperative course was uneventful. Clinical and radiological examinations (radiography and MRI) performed 6 months later did not show neurological deficit or recurrence of tumor (Figs. 3 and 4) . One year later radiography did not reveal any sign of recurrence, and the patient remained asymptomatic. Nevertheless he will continue to be followed up.
Our Pathological Anatomy Service confirmed the total excision with free edges of tumor (Fig. 5) . Histopathological findings consisted of multiple rounded calcified ossicles resembling psammoma bodies embedded in a hypercellular stroma characterized by spindle cells growing in fascicles with focal whorl formations. Some of the ossicles were calcified as in odontogenic fibromas (Fig. 6) . No mitotic figures were found. In the periphery the disposition was less cellular with a more fibrous component and a great number of reactive trabecular aspects. There was aneurysmal cystic degeneration. Immunohistochemical analysis was not performed. 
discussion terminology controversy
"Juvenile psammomatoid ossifying fibroma" has been referred to using different terminology, presenting a nomenclatural controversy between authors and pathologists before its name was settled. The lesion was first reported in 1938 by Benjamins, 2 who termed it "osteoid fibroma with atypical ossification." In 1949 Gögl 7 gave it the designation of "psammomatoid ossifying fibroma." The lesion was later named "juvenile active ossifying fibroma" by Johnson 11 in 1952. Johnson introduced the term "active" based on the aggressive and proliferating behavior of this pathology. Makek 16 called the lesion "psammous desmoosteoblastoma" as a variant of osteoblastoma. The second edition of the WHO classification of odontogenic tumors used the general term "juvenile ossifying fibroma" (JOF) to describe the lesion affecting the craniofacial skeleton in children under the age of 15 years. 14 Wenig et al., 25 who called the lesion "aggressive psammomatoid ossifying fibroma," added the adjective "aggressive" because of the lesion's potential for infiltrative growth and dropped the term "juvenile" because the entity was not confined to the younger age group. Hartstein et al. 9 were more simple in their description, calling it just "psammomatoid ossifying fibroma" with no allusion to a patient's age or the nature of the lesion. Table 1 ). Nowadays JPOF is a lesion with signature pathological features that make it a distinct entity.
etiology
Craniofacial fibro-osseous lesions compose a group of disorders characterized by the replacement of bone by a benign connective tissue matrix with varying amounts of mineralized substances. Johnson 11 suggested that JPOF can arise from junction sutures, which is a site that can produce ossicles and chondroid spheres. Some investigators have hypothesized that JPOF originates from an over- Recently, a new tumor suppressor gene (HRPT2) mutation has been related to ossifying fibroma, and it has been suggested that such lesions could arise as a result of the haploinsufficiency of that particular gene. 20 
clinical Features
Single case reports as well as several smaller series have appeared in the literature. The major series reported by Johnson et al. 12 and Makek, 16 with 112 and 86 cases, respectively, showed findings similar to JPOF. The majority of cases occurred in patients with an average age from 10-15 to 25-30 years, although a considerable number of cases referred to older patients. The entity is exceptional in very young patients; nevertheless, our case of JPOF occurred in a 6-year-old male child. A slight male predominance has been observed. The most common lesion sites were the paranasal sinuses and the jaw (70% in the paranasal sinuses, followed by 20% in the maxilla and 10% in the mandible), and just 10% occurred in the calvaria. In the mandible, JPOF used to occur more in the ramus than in the body of the mandible. The majority of single cases documented thus far have affected the sinonasal bones too, with a few occurring in the neurocranium. In the calvaria location, JPOF has been reported only rarely, with the anterior cranial fossa as the most frequent location. 3 As regards skull bones, single cases have been documented in the parietal, temporal, and frontal bones. 5 Normally JPOF progresses in an asymptomatic way with no clinical neurological deficits, but it depends on the lesion's location. As in the present case, calvarial JPOF has been discovered accidentally following a minor head injury or in the course of a diagnostic workup. In the facial area, the most commonly observed clinical manifestation has been proptosis. 16 Lateral displacement of the eyeball and decreasing vision have also been reported. If the lesion reaches the paranasal sinus, nasal obstruction, recurrent sinusitis, pain, and facial swelling may be other clinical findings. If the lesion occurs in the mandible, the symptoms often consist of painless local swelling. Juvenile psammomatoid ossifying fibroma grows slowly, although it is characterized by its invasive growth. Extension to the adjacent craniofacial cavities may vary from just pushing the adjacent bone to invasive growth and bone erosion of the nearby anatomical structures. 22 Aggressive growth has been observed in some cases, mainly for lesions in a maxillary location and in younger patients in the 1st and 2nd decades of life. 12 This behavior has been associated with aneurysmal bone cyst formation. The development of aneurysmal bone cyst seems to be a common transformation and is documented in many cases, as in our case. 16 The etiology and the predictive factors of cystic transformation remain unclear, but they may be related to genetic and/or environmental causes. 10 Clinically cyst formation has been the cause of accelerated tumor growth in a short period of time, although patients remain pain free and with no neurological deficit. The cyst occurs more commonly in children.
Despite the tumor's aggressive growth and recurrence rate, malignant transformation or cases of metastasis have not been reported until now. Complications due to direct intracranial extension with secondary encephalitis and meningitis have been reported. 12 
imaging characteristic
The radiological diagnosis of JPOF is suggested by the findings on CT with bone windows and MRI; however, radiological features can resemble other odontogenic lesions. In radiology, JPOF may show areas of "ground glass" with a lesion not encapsulated but separated with radiopaque borders. 18 Computed tomography studies show an expansive but circumscribed lesion with an abrupt transition of thick bone at the margin of the lesion. The internal appearance may be multiloculated. In CT bone windows, abnormal bone can be differentiated from the rest of the adjacent bony structures. Magnetic resonance imaging shows intensities similar to the gray matter of the brain on precontrast T1-weighted images and low intensities on T2-weighted sequences. Gadolinium contrast MRI may show enhancement of the thick outer extradural lesion. In the mandible the lesion may appear circumscribed and expansive with calcified matrices. In the sinonasal area the lesion can protrude into an air-filled space, keeping the margin clearly demarcated, although in this area the lesion could show a disrupted margin surrounding the bony structure.
histopathology
Juvenile psammomatoid ossifying fibroma is one of the benign fibro-osseous lesions that belong to a diverse group of conditions with common histopathological features. These lesions may show hypercellular fibroblastic vascular stroma, with a variety of calcified matrices represented by woven bone and lamellar bone, curvilinear trabeculae, and calcifications. However, JPOF is characterized by the presence of multiple round, uniform small masses of osteoid with calcifications in a concentric pattern, imparting a psammoma body-like appearance. These ossicles can resemble dental cementum but may have an osteoid rim. The nonosseous component can vary from densely cellular to loose, with cellular proliferation of uniform fibroblastic spindle cells and multinucleate osteoclast-like giant cells. 22 Mitotic figures are extremely rare, and neither atypia nor necrosis is identified. As discussed earlier in this report, the development of aneurysmal bone cyst in JPOF has been reported. It begins with focal myxoid changes and microcystic spaces in the stroma, and gradual expansion of the cyst can form a thin fibrous wall. Aggregates of osteoclast-like giant cells or hemorrhage may appear in association with cystic change.
Immunohistochemistry is not routinely performed to diagnose. Stromal cells of JPOF usually express vimentin, epithelial membrane antigen (EMA), smooth muscle actin (SMA) and CD10, with a lack of expression of CD34, S100 protein, and cytokeratins. 8 The proliferation index (Ki 67) is frequently low and not useful to predict aggressive behavior. 10 Little is known about the aggressive biological behavior of this lesion.
differential diagnostic
The identification of JPOF as a distinct type of odon-togenic lesion is important considering the potential for local aggressive behavior, and in children the differential diagnosis of a skull tumor differs from that in the adult population. Juvenile psammomatoid ossifying fibroma and FD are 2 fibro-osseous lesions with overlapping features but with different disease progression. In contrast to JPOF, FD is a poorly circumscribed bony expansion not encapsulated by a thin cortex with various degrees of radiopacity on neuroimaging studies. 28 Histopathological characteristics of FD consist of cellular fibrous tissue with spindle-shaped cells with irregularly shaped trabeculae of woven bone with no osteoblastic rimming.
7 Fibrous dysplasia has been linked to genetic alterations of GNAS1.
The 2 types of JOF-JPOF and JTOF-are easily differentiated by their histopathological features and the patient's condition. 12 Juvenile trabecular ossifying fibroma occurs in younger patients than JPOF 17 and usually arises in the craniofacial bones, especially around the paranasal sinuses and orbits. Juvenile trabecular ossifying fibroma is characterized by progressive and rapid growth leading to facial asymmetry. On neuroimaging JTOF is a welldefined unilocular or multilocular radiolucent mass with cortical thinning and perforation. Microscopic examination of JTOF contains a cell-rich fibroblastic spindle cell stroma, osteoid matrix, and trabeculae of immature woven bone. 23 Progressive calcification of the osteoid results in anastomosing trabeculae of immature woven bone.
Juvenile psammomatoid ossifying fibroma may be confused with cementum-forming neoplasms, such as cementoblastoma or cementifying fibroma. However this kind of tumor occurs frequently in the 3rd and 4th decades and develops in the mandibular premolar-molar area. These lesions produce "cementum-like" material, structures called "droplets" or "cementicles," which show oval mineralized spherules. 10 The clinical differential diagnosis includes primary extracranial psammomatoid meningioma (PEPM). Juvenile psammomatoid ossifying fibroma may be difficult to distinguish from PEPM given the macroscopic anatomical superficial similarity, neurocranial location, and radiological aspects. Primary extracranial psammomatoid meningioma is an uncommon pathology, just 2% of all meningiomas. They may arise from heterotopic rests of arachnoid cells in locations such as the nasal cavity, paranasal sinuses, and nasopharynx 24 and show an irregular bone surface. Histopathologically in psammomatoid meningioma there is a random distribution of psammoma bodies, which are rimmed by a group of osteoclasts and osteoblasts. Psammomatoid meningioma is immunoreactive for epithelial membrane antigen and vimentin, a differential characteristic of PEPM. However most meningiomas show meningothelial cells that react positive for antibodies directed against S100 protein, and CD10 is expressed in a high percentage of PEPMs. 8 Benign skull base lesions in children such as primary intraosseous cavernous hemangioma or eosinophilic granuloma have to be considered. Cavernous hemangiomas of the skull are extremely rare tumors usually established in frontal and parietal bones. As they enlarge, they may cause periodic severe headaches. On CT they demonstrate reactive osteoclastic and osteoblastic remodeling, with the characteristic trabeculated honeycomb configurations. Microscopically, intraosseous cavernous hemangiomas are composed of thin-walled vascular channels lined by a single layer of flattened endothelial cells interspersed among bony trabeculae.
19 Eosinophilic granuloma, a variety of histiocytosis X, is a benign disorder that affects children and young adults too. The clinical and radiographic findings are often not specific enough to determine the diagnosis, but the key feature is the identification of Langerhans cells. 13 
therapeutic management
The recommended treatment must be complete excision of the tumor. Recurrence after partial or incomplete resection is common, ranging from 30% to 56%. [1] [2] [3] [4] 7 Lesions with significant cortical destruction and periosteal elevation have an increased risk of recurrence. Resection requires tumor-free margins for the preservation of important adjacent structures as much as possible. Recurrence can depend on the difficulty of excision in certain locations and the infiltrative tumor borders. In a cranium location, open surgical management is strongly preferred inasmuch as it allows greater visibility and exposure of the tumor and adjacent areas of extension (ethmoid and frontal sinuses, orbit, and so forth); however, an endoscopic endonasal approach has been used alone or in combination with a second open surgery. 21 At the time of tumor excision, reconstruction must be performed if possible. Surgical complications may appear as blood loss requiring transfusion or in cases of tumor associated with the anterior cranial base, or secondary complications can occur as a direct result of the destruction of vital structures. 18 For JPOF in the calvaria, bone grafts or other osteogenic materials can be used. For large tumors of the anterior cranial fossa, the skull defect can be reconstructed with a periosteal pedicle and an absorbable mesh to reduce comorbidity and improve survival. 15 Regardless of the approach, close clinical and radiological follow-up is essential to detect and treat recurrences. In cases of subtotal resection, adjuvant treatment is not indicated. Radiotherapy is contraindicated due to the radioresistance of JPOF, and chemotherapy is not necessary in this kind of tumor. 22 Clinical guidelines of follow-up protocols have not yet been standardized in the literature, but re-excision should be considered. Recurrence can be observed after a period ranging from 6 months to 19 years.
conclusions
Juvenile psammomatoid ossifying fibroma is a variety of ossifying fibroma with unique histopathological features that configure its identity. The lesion commonly affects young people, with a predilection for the jaw and sinonasal region. A calvarial location is rare, but neurosurgeons must consider this entity in the differential diagnoses of skull lesions because its aggressive growth and local invasion need special surgical considerations and close clinical and radiological follow-up. On neuroimaging JPOF can appear as a circumscribed lesion with a degree of calcifications and cystic changes. Histologically its signature characteristic is a cellular fibrous stroma with spheroid calcifications such as psammoma bodies. Treatment must be complete excision with free margins. Despite the partial or incomplete resection results in recurrences, JPOF has a good prognosis.
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